Metacrine Receives $25,616,649 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c754bfe-81cf-4dae-945a-3d6caeafc865 - Date
11/10/2016 - Company Name
Metacrine - Mailing Address
12780 El Camino Real San Diego, CA 92130 USA - Company Description
Metacrine is a biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the Salk Institute. - Website
http://www.metacrine.com - Transaction Type
Venture Equity - Transaction Amount
$25,616,649 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 20 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
